Presidio Capital Management »

Nautilus Biotechnology shares owned by Presidio Capital Management

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Presidio Capital Management from 13F filings

Historical chart of Presidio Capital Management investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Presidio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Presidio Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 10k 2.94
2023-12-31 $30k 10k 2.99

More positions owned by Presidio Capital Management

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Smid Risng Etf (SDVY)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
First Tr Exchange-traded Senior Ln Fd (FTSL)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Apple (AAPL)
General Dynamics Corporation (GD)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Presidio Capital Management

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
BlackRock
Vanguard Group
Comprehensive Financial Management
Bain Capital Life Sciences Investors
Amazon
Geode Capital Management
Clarius
Northern Trust
Dimensional Fund Advisors
Alyeska Investment Group
Morgan Stanley

View all funds holding Nautilus Biotechnology